Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides
- 479 Downloads
Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion.
Materials and Methods
The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis.
The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain.
Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.
KeywordsProteus mirabilis complement lipopolysaccharide outer-membrane protein
- Amano K, Cedzyński M, Swierzko AS et al (1996) Comparison of serological reactions of Rickettsiae-infected patients and rabbit anti-Proteus OX antibodies with Proteus OX2, OX19 and OXK lipopolysaccharides. Arch Immunol Ther Exp 44: 235–240Google Scholar
- Besucher HU, Brade V (1986) Lipopolysaccharides as complement inhibitors by complex formation with purified third complement component (C3). Immunobiology 173: 41–55Google Scholar
- Cisowska AG, Bugla-Ploskonska A, Gamian W et al (2005) Relationship between susceptibility to bactericidal action of serum and outer membrane protein patterns in E. coli K1 strains. Pol J Environ Stud 14: 476–482Google Scholar
- Doroszkiewicz W, Lachowicz TM (1989) Mechanism of antigenic variation in Shigella flexnerii bacilli. I. Selective lethal effect of normal sera on mixed population of S. flexnerii 1b serotype and its antigenic 3b mutant. Arch Immunol Ther Exp 37: 693–701Google Scholar
- Nordin Fredrikson G, Truedsson L, Sjöholm AG et al (1999) DNA analysis in MHC heterozygous patient with complete C4 deficiency – homozygosity for C4 gene deletion and C4 pseudogene. Exp Clin Immunogenet 8: 29–37Google Scholar
- Lachowicz TM, Doroszkiewicz W (1996) Sensitivity to complement as a factor of antigenic variation I Shigella flexnerii. Bull Pol Acad Biol Sci 44: 255–260Google Scholar
- Lachowicz TM, Doroszkiewicz W, Niedbach J (1999) Environment implication of lipopolysaccharide dependent normal serum sensitivity of Shigella flexnerii serotypes. Nova Acta Leopoldina 312: 235–243Google Scholar
- Vinogradov EV, Thomas-Oates JE, Brade H et al (1994) Structural investigation of the lipopolysaccharide from Proteus mirabilis R45 (Re-chemotype). J Endotoxin Res 1: 199–206Google Scholar
- Westphal O, Jann K (1965) Bacterial lipopolysaccharides: extraction with phenol-water and further application of the procedure. Methods Carbohydr Chem 5: 83–89Google Scholar